Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosis.
Schutz C, Chirehwa M, Barr D, Ward A, Janssen S, Burton R, Wilkinson RJ, Shey M, Wiesner L, Denti P, McIlleron H, Maartens G, Meintjes G.
Schutz C, et al. Among authors: mcilleron h.
Br J Clin Pharmacol. 2020 May;86(5):966-978. doi: 10.1111/bcp.14207. Epub 2020 Feb 17.
Br J Clin Pharmacol. 2020.
PMID: 31912537
Free PMC article.